Mindray North America FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 22, 2024
  • 2 Class I recalls
  • Last warning letter 2012
Inspections 7 2 OAI
Recalls 56 2 Class I (4%)
Warning letters 1 Latest Nov 29, 2012
510(k) clearances 6 Latest May 16, 2014

Mindray North America has 56 FDA recalls (2 Class I), 7 inspections, 6 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Mindray North America, the most recent on Nov 29, 2012.

What these totals cover: FDA records filed under the name "Mindray North America" and its spelling variants "Mindray Ds Usa, Inc. Dba Mindray North America", "Mindray Ds Usa", "Mindray Ds Usa, Inc. D.B.A. Mindray North America".

Latest recall
Z-0112-2027 · Class III · Aug 31, 2026
Latest inspection
Feb 22, 2024 · NAI
Latest 510(k)
May 16, 2014

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls56 (2 Class I)Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances6Nov 15, 2026File dated Nov 9, 2026Current
Inspections7Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Mindray North America's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Mindray North America: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 5 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 6 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 2 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2026: 0 inspections (0 OAI), 0 warning letters, 8 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202600080
202500040
202410040
202300000
202200000
202100020
202000010
201900060
201810030
201700050

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Mindray North America as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Mindray North America yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Mindray North America FDA Warning Letters

1 warning letter on Nov 29, 2012.

IssuedSubjectIssuing officeClose-out letter
Nov 29, 2012 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

56 recall records from Aug 11, 2010 to Aug 31, 2026. Showing the 20 most recent. View all 56 recall records

NumberClassProductDate
Z-0112-2027Class IIIPanorama and Telemetry Monitoring System. Operator's Manuals: TMS-6016/Panorama Telepack-608/TMS60…Aug 31, 2026
Z-0109-2027Class IIIePM Series Patient Monitor. Patient Monitor Series: ePM 10M/ePM 12M/ePM 12MA/ ePM 15M/ePM 10AAug 31, 2026
Z-0114-2027Class IIIPassport Series Patient Monitor. Operator's Manuals: 8 / 12 / 12M / 17M / VAug 31, 2026
Z-0110-2027Class IIIBeneVision N1 and N-Series Patient Monitor. Patient Monitor: N12/N15/N17/N19/N22.Aug 31, 2026
Z-0113-2027Class IIIBeneView Series. Operator's Manuals: T5 / T8Aug 31, 2026
Z-0111-2027Class IIIBeneVision Series Telemetry Monitor. Operator's Manuals: TM70/TM80Aug 31, 2026
Z-0116-2027Class IIIT1 Patient Monitor. Operator's Manual: T1 Patient MonitorAug 31, 2026
Z-0115-2027Class IIIcPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12Aug 31, 2026
Z-0920-2026Class IIHardware configuration of the BeneVision Central Monitoring System (CMS), marketed as BeneVision…Nov 18, 2025
Z-0720-2026Class IISevoflurane (SEVO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following…Oct 20, 2025
Z-0721-2026Class IIIsoflurane (ISO) V90 Electronic Vaporizer with the A9 Anesthesia System. Labeled as the following…Oct 20, 2025
Z-2622-2025Class IIBeneVision N1 Patient Monitor (N1). Part Numbers: 6660E-PA00017, 6660E-PA00014, 6660E-PA00012…Aug 15, 2025
Z-2952-2024Class IIDesflurane E_Vap.(Saf-T-Fill) used with the A9 Anesthesia System-Used to provide the vapor of an…Jul 22, 2024
Z-2950-2024Class IISevoflurane E_Vap.(Safety Filling adapter) used with the A9 Anesthesia System-Used to provide the…Jul 22, 2024
Z-2949-2024Class IISevoflurane E_Vap.(Quik-Fil):used with the A9 Anesthesia System-Used to provide the vapor of an…Jul 22, 2024
Z-2951-2024Class IIIsoflurane E_Vap.(Safety Filling adapter): used with the A9 Anesthesia System-Used to provide the…Jul 22, 2024
Z-2108-2021Class III3AA battery cradle (Part Number 045-001699-01) used with BeneVision TD60 Telepack (Model Number…May 27, 2021
Z-1254-2021Class IIMindray BeneVision Distributed Monitoring System( DMS) 1. p/n 115-051209-00 2. p/n 115-034414-00…Feb 22, 2021
Z-1330-2020Class IIDP-30 Digital Ultrasonic Diagnostic Imaging System, Part No. 1155E-PA00004 - Product Usage: The…Jan 13, 2020
Z-0920-2020Class IIBA-800M Chemistry Analyzer Part Numbers BA81E-PA00002 and BA81E-PA00003, Containing Gas spring…Dec 9, 2019

Recent FDA inspections

7 inspections from Jun 10, 2010 to Feb 22, 2024.

DateSiteProductClassificationFEI
Feb 22, 2024Mahwah, NJDevicesNo Action Indicated (NAI)2221819
Apr 20, 2018Mahwah, NJDevicesNo Action Indicated (NAI)2221819
Mar 31, 2016Mahwah, NJDevicesOfficial Action Indicated (OAI)2221819
Mar 10, 2015Mahwah, NJDevicesVoluntary Action Indicated (VAI)2221819
Sep 23, 2013Mahwah, NJDevicesVoluntary Action Indicated (VAI)2221819
Aug 2, 2012Mahwah, NJDevicesOfficial Action Indicated (OAI)2221819
Jun 10, 2010Mahwah, NJDevicesVoluntary Action Indicated (VAI)2221819
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Mindray North America: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Nov 29, 2012.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2221819Mahwah, NJ7Feb 22, 2024

Recent 510(k) clearances

6 510(k) clearances from Sep 10, 2010 to May 16, 2014.

K-NumberDeviceDate
K132037VITAL SIGNS MONITORMay 16, 2014
K132038ACCUTORR 7 VITAL SIGNS MONITORMay 2, 2014
K132075PASSPORT M SERIES PATIENT MONITORING (INCLUDING MODELS PASSPORT 17M AND PASSPORT 12M)Apr 18, 2014
K132026V SERIES MONITORING SYSTEM, 12.1 DCU/V12 AND 21.0 DCU/V21Dec 20, 2013
K102471AS3700 ANESTHSIA DELIVERY SYSTEMFeb 11, 2011
K102004ENDEAVOUR MONITORING SYSTEMSep 10, 2010

Mindray North America and the FDA: common questions

Has Mindray North America received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Mindray North America. The most recent is dated Nov 29, 2012.

Has Mindray North America received an FDA Form 483?

FDA has not published a Form 483 for "Mindray North America" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Mindray North America?

The most recent FDA inspection on file ended Feb 22, 2024 at Mahwah, NJ and was classified NAI. FDA has 7 inspections of Mindray North America on file, 2 of them classified OAI (official action indicated).

Has Mindray North America had an FDA recall?

Yes. Mindray North America has 56 FDA recalls on record, 2 of them Class I, the most serious class. The most recent started Aug 31, 2026.

Need more than this page shows? Ask about Mindray North America in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.